A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy

References

• LippunerKOsteoporosis: a global challenge?Ther Umsch2012693135136 German22470962
   PubMedGoogle Scholar
• MeltonLJ3rdJohnellOLauEMautalenCASeemanEOsteoporosis and the global competition for health care resourcesJ Bone Miner Res20041971055105815176986
   PubMedGoogle Scholar
• NikJLaiPSNgCJEmmertonLA qualitative study of community pharmacists’ opinions on the provision of osteoporosis disease state management services in MalaysiaBMC Health Serv Res20161644827577560
   PubMedGoogle Scholar
• HøibergMPRubinKHHermannAPBrixenKAbrahamsenBDiagnostic devices for osteoporosis in the general population: a systematic reviewBone201692586927542659
   PubMedGoogle Scholar
• SiposWPietschmannPRaunerMStrategies for novel therapeutic approaches targeting cytokines and signaling pathways of osteoclasto- and osteoblastogenesis in the fight against immune-mediated bone and joint diseasesCurr Med Chem200815212713618220768
   PubMedGoogle Scholar
• RodanGAMartinTJTherapeutic approaches to bone diseasesScience200028954841508151410968781
   PubMed Web of Science ®Google Scholar
• YuBWangCYOsteoporosis: the result of an ‘aged’ bone microenvironmentTrends Mol Med201622864164427354328
   PubMedGoogle Scholar
• YangYMLiPCuiDCEffect of aged bone marrow microenvironment on mesenchymal stem cell migrationAge (Dordr)20153721625693923
   PubMedGoogle Scholar
• SunYYeXCaiMOsteoblast-targeting-peptide modified nanoparticle for siRNA/microRNA deliveryACS Nano20161065759576827176123
   PubMed Web of Science ®Google Scholar
• GuoHHYuCCSunSXAdenovirus-mediated siRNA targeting TNF-α and overexpression of bone morphogenetic protein-2 promotes early osteoblast differentiation on a cell model of Ti particle-induced inflammatory response in vitroBraz J Med Biol Res2013461083183824141610
   PubMedGoogle Scholar
• KatsuyamaTOtsukaFTerasakaTRegulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2Peptides201573889426409788
   PubMedGoogle Scholar
• NewaMLamMBhandariKHXuBDoschakMRExpression, characterization, and evaluation of a RANK-binding single chain fraction variable: an osteoclast targeting drug delivery strategyMol Pharm2014111818924171467
   PubMedGoogle Scholar
• LiuJDangLLiDA delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclastsBiomaterials20155214816025818421
   PubMed Web of Science ®Google Scholar
• ReidIRHeapSWKingARIbbertsonHKTwo-year follow-up of biphosphonate (APD) treatment in steroid osteoporosisLancet19882862011442903360
   PubMedGoogle Scholar
• KhajuriaDKVasireddiRTrebbinMKarasikDRazdanRNovel therapeutic intervention for osteoporosis prepared with strontium hydroxyapatite and zoledronic acid: in vitro and pharmacodynamic evaluationMater Sci Eng C Mater Biol Appl20177169870827987763
   PubMed Web of Science ®Google Scholar
• MozzatiMArataVGallesioGTooth extraction in osteoporotic patients taking oral bisphosphonatesOsteoporos Int20132451707171223288026
   PubMedGoogle Scholar
• AdairJEWeitzmanMDApplying the speed-dating model and other approaches to foster future leaders for the American Society of Gene and Cell TherapyMol Ther20142281397139825082084
   PubMedGoogle Scholar
• ChenHChenLSunLZhenHLiXZhangQA small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancerGastric Cancer201114433935221538018
   PubMed Web of Science ®Google Scholar
• HydbringPBadalian-VeryGClinical applications of microRNAsF1000Res2013213624627783
   PubMedGoogle Scholar
• GizaDEFuentes-MatteiEBullockMDCellular and viral microRNAs in sepsis: mechanisms of action and clinical applicationsCell Death Differ201623121906191827740627
   PubMed Web of Science ®Google Scholar
• YanokuraMBannoKIidaMMicroRNAS in endometrial cancer: recent advances and potential clinical applicationsEXCLI J20151419019826535032
   PubMedGoogle Scholar
• ChengKWHsuSHA facile method to prepare superparamagnetic iron oxide and hydrophobic drug-encapsulated biodegradable polyurethane nanoparticlesInt J Nanomedicine2017121775178928280341
   PubMed Web of Science ®Google Scholar
• TivnanAOrrWSGubalaVInhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticlesPLoS One201275e3812922662276
   PubMed Web of Science ®Google Scholar
• YigitMVGhoshSKKumarMContext-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasisOncogene20173618262827841862
   PubMedGoogle Scholar
• RaiKTakigawaNItoSLiposomal delivery of microRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cellsMol Cancer Ther20111091720172721712475
   PubMedGoogle Scholar
• OhnoSITakanashiMSudoKSystemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cellsMol Ther201321118519123032975
   PubMed Web of Science ®Google Scholar
• YuSDingJHeCCaoYXuWChenXDisulfide cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapyAdv Healthc Mater20143575276024574261
   PubMedGoogle Scholar
• GencturkAKahramanEGüngörSOzhanGOzsoyYSaracASPolyurethane/hydroxypropyl cellulose electrospun nanofiber mats as potential transdermal drug delivery system: characterization studies and in vitro assaysArtif Cells Nanomed Biotechnol201745365566427103498
   PubMed Web of Science ®Google Scholar
• AkdumanCOzgüneyIKumbasarEPPreparation and characterization of naproxen-loaded electrospun thermoplastic polyurethane nanofibers as a drug delivery systemMater Sci Eng C Mater Biol Appl20166438339027127068
   PubMed Web of Science ®Google Scholar
• WangDMillerSCShlyakhtenkoLSOsteotropic peptide that differentiates functional domains of the skeletonBioconjug Chem20071851375137817705416
   PubMed Web of Science ®Google Scholar
• CarinciFRestoration of incisor area using one-piece implants: evaluation of crestal bone resorptionDent Res J (Isfahan)20129Suppl 2S151S15423814574
   PubMedGoogle Scholar
• MizoguchiFMurakamiYSaitoTMiyasakaNKohsakaHmiR-31 controls osteoclast formation and bone resorption by targeting RhoAArthritis Res Ther2013155R10224004633
   PubMed Web of Science ®Google Scholar
• EllBKangYMicroRNAs as regulators of bone homeostasis and bone metastasisBonekey Rep2014354925120906
   PubMedGoogle Scholar
• LiKZhangJYuJMicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4J Biol Chem2015290138185819525657009
   PubMed Web of Science ®Google Scholar
• WuYLiZYangMMicroRNA-214 regulates smooth muscle cell differentiation from stem cells by targeting RNA-binding protein QKIOncotarget2017812198661987828186995
   PubMedGoogle Scholar
• WangXGuoBLiQmiR-214 targets ATF4 to inhibit bone formationNat Med20131919310023223004
   PubMed Web of Science ®Google Scholar
• ZhaoCSunWZhangPmiR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathwayRNA Biol201512334335325826666
   PubMed Web of Science ®Google Scholar
• WangXChenJLiFMiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-cateninBiochem Biophys Res Commun2012428452553123068095
   PubMedGoogle Scholar
• WangXShenEWangYCross talk between miR-214 and PTEN attenuates glomerular hypertrophy under diabetic conditionsSci Rep201663150627549568
   PubMed Web of Science ®Google Scholar
• WuCGongFPangPAn RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude micePLoS One201386e6641623922634
   PubMed Web of Science ®Google Scholar
• SlamonDJGodolphinWJonesLAStudies of the HER-2/neu proto-oncogene in human breast and ovarian cancerScience198924449057077122470152
   PubMed Web of Science ®Google Scholar
• ChoiKYSilvestreOFHuangXA nanoparticle formula for delivering siRNA or miRNAs to tumor cells in cell culture and in vivoNat Protoc2014981900191525033207
   PubMed Web of Science ®Google Scholar
• DingMSongNHeXToward the next-generation nanomedicines: design of multifunctional multiblock polyurethanes for effective cancer treatmentACS Nano2013731918192823411462
   PubMedGoogle Scholar
• KhatriNBaradiaDVhoraIRathiMMisraAcRGD grafted liposomes containing inorganic nano-precipitate complexed siRNA for intra-cellular delivery in cancer cellsJ Control Release2014182455724631861
   PubMed Web of Science ®Google Scholar
• ZhouHFYanHPanHPeptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritisJ Clin Invest2014124104363437425157820
   PubMed Web of Science ®Google Scholar
• IwaniecUTWronskiTJLiuJPTH stimulates bone formation in mice deficient in Lrp5J Bone Miner Res200722339440217147489
   PubMedGoogle Scholar
• TanakaSOsteoporosis in rheumatoid arthritis: role of osteoclast differentiation and cytokinesClin Calcium2001115598601 Japanese15775560
   PubMedGoogle Scholar
• BinderNBNiederreiterBHoffmannOEstrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosisNat Med200915441742419330010
   PubMed Web of Science ®Google Scholar
• SatoYTandoTMoritaMSelective estrogen receptor modulators and the vitamin D analogue eldecalcitol block bone loss in male osteoporosisBiochem Biophys Res Commun201748241430143627974229
   PubMedGoogle Scholar
• GjoksiBGhayorCSiegenthalerBRuangsawasdiNZenobi-WongMWeberFEThe epigenetically active small chemical N-methyl pyrrolidone (NMP) prevents estrogen depletion induced osteoporosisBone20157811412125959414
   PubMedGoogle Scholar
• MazziottiGFormentiAMAdlerRAGlucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/vitamin D axes, treatment options and guidelinesEndocrine201654360361127766553
   PubMed Web of Science ®Google Scholar
• BarbehennEKLuriePWolfeSMOsteosarcoma risk in rats using PTH 1-34Trends Endocrinol Metab200112938311595538
   PubMedGoogle Scholar
• HecktTKellerJPetersSParathyroid hormone induces expression and proteolytic processing of Rankl in primary murine osteoblastsBone201692859327554428
   PubMedGoogle Scholar
• SchwarzEMRitchlinCTClinical development of anti-RANKL therapyArthritis Res Ther20079Suppl 1S7
   PubMed Web of Science ®Google Scholar
• AhoJEdingerMBotkerJBaldursdottirSRantanenJOscillatory shear rheology in examining the drug-polymer interactions relevant in hot melt extrusionJ Pharm Sci2016105116016726852851
   PubMedGoogle Scholar
• KhajuriaDKDishaCVasireddiRRazdanRMahapatraDRRisedronate/zinc-hydroxyapatite based nanomedicine for osteoporosisMater Sci Eng C Mater Biol Appl201663788727040198
   PubMed Web of Science ®Google Scholar
• CaoJWangRGaoNA7RC peptide modified paclitaxel liposomes dually target breast cancerBiomater Sci20153121545155426291480
   PubMedGoogle Scholar
• XiaoYReisLAFericNDiabetic wound regeneration using peptide-modified hydrogels to target re-epithelializationProc Natl Acad Sci U S A201611340E5792E580127647919
   PubMedGoogle Scholar
• CamachoKMMenegattiSMitragotriSLow-molecular-weight polymer-drug conjugates for synergistic anticancer activity of camptothecin and doxorubicin combinationsNanomedicine (Lond)20161191139115127079141
   PubMed Web of Science ®Google Scholar
• SunWZhaoCLiYOsteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activityCell Discov201621601527462462
   PubMed Web of Science ®Google Scholar
• WangYGraingerDWRNA therapeutics targeting osteoclast-mediated excessive bone resorptionAdv Drug Deliv Rev201264121341135721945356
   PubMedGoogle Scholar
• SuzukiMHashizumeMYoshidaHShiinaMMiharaMIntercellular adhesion molecule-1 on synovial cells attenuated interleukin-6-induced inhibition of osteoclastogenesis induced by receptor activator for nuclear factor κB ligandClin Exp Immunol20111631889521039424
   PubMedGoogle Scholar
• KitauraHKimuraKIshidaMKoharaHYoshimatsuMTakano-YamamotoTImmunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivoClin Dev Immunol2013201318184923762085
   PubMedGoogle Scholar
• WangLLiuSZhaoYOsteoblast-induced osteoclast apoptosis by Fas ligand/FAS pathway is required for maintenance of bone massCell Death Differ201522101654166425744024
   PubMedGoogle Scholar
• KimJHKimKYounBUJinHMKimNMHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCARCell Signal20102291341134920466061
   PubMedGoogle Scholar